An Act relative to promoting healthcare access and affordability for patients

This bill requires health insurers and pharmacy benefit managers to pass at least 80% of estimated drug rebates directly to patients by reducing their out-of-pocket costs at the pharmacy, rather than keeping the savings. Insurers must report compliance annually to the state commissioner, with potential fines for non-compliance, while protecting rebate details as confidential business information. Additionally, it mandates a state analysis of barriers to accessing cell and gene therapies for MassHealth patients, including projected costs, reimbursement frameworks, and infrastructure needs through 2037, with specific focus on impacts on vulnerable populations.